Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 7 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2026 Filed Mar 11, 2026 16:52 UTC |
Boyd Peter E.Chief People Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 42,500 | $4.29 Strike: $4.29 | $182,325.00 |
DisclosureSEC source: 0001214659-26-003147 · marketforms-72463.xml · derivative · entry 3 Boyd Peter E. · CIK 0001739816 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 42,500 shares Expires 2036-03-09 F4 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 16:52 UTC |
Boyd Peter E.Chief People Officer
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-003147 · marketforms-72463.xml · nonDerivative · entry 1 Boyd Peter E. · CIK 0001739816 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,323 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 16:50 UTC |
Jung CassieChief Operating Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 42,500 | $0.00 Strike: $4.29 | $0.00 |
DisclosureSEC source: 0001214659-26-003141 · marketforms-72467.xml · derivative · entry 4 Jung Cassie · CIK 0001960154 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 42,500 shares Expires 2036-03-09 F4 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 16:50 UTC |
Jung CassieChief Operating Officer
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-003141 · marketforms-72467.xml · nonDerivative · entry 2 Jung Cassie · CIK 0001960154 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,771 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 16:52 UTC |
Cioffi MelinaSVP, Regulatory Affairs
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 75,000 | $4.29 Strike: $4.29 | $321,750.00 |
DisclosureSEC source: 0001214659-26-003144 · marketforms-72465.xml · derivative · entry 3 Cioffi Melina · CIK 0002066841 · SVP, Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2036-03-09 F4 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 16:52 UTC |
Cioffi MelinaSVP, Regulatory Affairs
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-003144 · marketforms-72465.xml · nonDerivative · entry 1 Cioffi Melina · CIK 0002066841 · SVP, Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,178 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 16:49 UTC |
Davis Matthew W.Chief Development Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.29 | $0.00 |
DisclosureSEC source: 0001214659-26-003140 · marketforms-72466.xml · derivative · entry 2 Davis Matthew W. · CIK 0002094283 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-03-09 F2 · derivative.exercise_date: The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 16:49 UTC |
Davis Matthew W.Chief Development Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-003140 · marketforms-72466.xml · nonDerivative · entry 1 Davis Matthew W. · CIK 0002094283 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 13:25 UTC |
Greenhawt Matthew J.Chief Medical Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 50,000 | $4.29 Strike: $4.29 | $214,500.00 |
DisclosureSEC source: 0001214659-26-003134 · marketforms-72376.xml · derivative · entry 3 Greenhawt Matthew J. · CIK 0002113518 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-03-09 F2 · derivative.exercise_date: The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 13:25 UTC |
Greenhawt Matthew J.Chief Medical Officer
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-003134 · marketforms-72376.xml · nonDerivative · entry 2 Greenhawt Matthew J. · CIK 0002113518 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 18:06 UTC |
Boyd Peter E.Chief People Officer
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-017652 · marketforms-71415.xml · nonDerivative · entry 1 Boyd Peter E. · CIK 0001739816 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,323 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 15:39 UTC |
Cioffi MelinaSVP, Regulatory Affairs
|
Tax withholdingCommon Stock | 2,083 | $5.93 | $12,352.19 |
DisclosureSEC source: 0001214659-25-017591 · marketforms-71360.xml · nonDerivative · entry 1 Cioffi Melina · CIK 0002066841 · SVP, Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,178 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 14:35 UTC |
Davis Matthew W.Chief Development Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001214659-25-016275 · marketforms-71182.xml · derivative · entry 2 Davis Matthew W. · CIK 0002094283 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-11-10 F2 · derivative.exercise_date: The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 14:35 UTC |
Davis Matthew W.Chief Development Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-016275 · marketforms-71182.xml · nonDerivative · entry 1 Davis Matthew W. · CIK 0002094283 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 18:01 UTC |
Jung CassieChief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.10 | $0.00 |
DisclosureSEC source: 0001214659-25-015048 · marketforms-71051.xml · derivative · entry 4 Jung Cassie · CIK 0001960154 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2031-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F3 · derivative.exercise_date: This option was granted on June 10, 2021 and is fully vested. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 18:01 UTC |
Jung CassieChief Operating Officer
|
SaleCommon Stock | 67,575 | $7.01 | $473,700.75 |
DisclosureSEC source: 0001214659-25-015048 · marketforms-71051.xml · nonDerivative · entry 3 Jung Cassie · CIK 0001960154 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 240,771 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 18:01 UTC |
Jung CassieChief Operating Officer
|
Exercise / conversionCommon Stock | 25,000 | $3.10 | $77,567.50 |
DisclosureSEC source: 0001214659-25-015048 · marketforms-71051.xml · nonDerivative · entry 2 Jung Cassie · CIK 0001960154 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 308,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 18:01 UTC |
Kraus Carl NChief Medical Officer
|
SaleCommon Stock | 20,272 | $7.00 | $141,904.00 |
DisclosureSEC source: 0001214659-25-015047 · marketforms-71050.xml · nonDerivative · entry 1 Kraus Carl N · CIK 0001946475 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 282,475 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. F2 · price: The reported transaction involves sale transactions from $7.00 to $7.02 per share. The weighted average price per share was $7.00. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 18:00 UTC |
Boyd Peter E.See Remarks
|
SaleCommon Stock | 10,000 | $7.00 | $70,000.00 |
DisclosureSEC source: 0001214659-25-015046 · marketforms-71047.xml · nonDerivative · entry 1 Boyd Peter E. · CIK 0001739816 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,323 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. Read SEC document |
| September 26, 2025 Filed Sep 29, 2025 20:26 UTC |
Barber DanielDirector · President and CEO
|
SaleCommon Stock | 91,343 | $6.03 | $551,191.06 |
DisclosureSEC source: 0001214659-25-014288 · marketforms-70872.xml · nonDerivative · entry 1 Barber Daniel · CIK 0001742266 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 923,430 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. F2 · price: The reported transaction involves sale transactions from $6.00 to $6.11 per share. The weighted average price per share was $6.0343. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price. Read SEC document |
| September 26, 2025 Filed Sep 29, 2025 20:26 UTC |
Boyd Peter E.See Remarks
|
SaleCommon Stock | 10,000 | $6.30 | $63,000.00 |
DisclosureSEC source: 0001214659-25-014287 · marketforms-70873.xml · nonDerivative · entry 1 Boyd Peter E. · CIK 0001739816 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,323 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. Read SEC document |
| September 19, 2025 Filed Sep 22, 2025 21:25 UTC |
Barber DanielDirector · President and CEO
|
SaleCommon Stock | 400 | $6.00 | $2,400.00 |
DisclosureSEC source: 0001214659-25-014009 · marketforms-70823.xml · nonDerivative · entry 1 Barber Daniel · CIK 0001742266 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,014,773 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. Read SEC document |
| September 05, 2025 Filed Sep 8, 2025 21:13 UTC |
Boyd Peter E.See Remarks
|
SaleCommon Stock | 15,000 | $5.30 | $79,500.00 |
DisclosureSEC source: 0001214659-25-013485 · marketforms-70566.xml · nonDerivative · entry 1 Boyd Peter E. · CIK 0001739816 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 288,323 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 23:06 UTC |
Jung CassieChief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.71 | $0.00 |
DisclosureSEC source: 0001214659-25-013493 · marketforms-70687.xml · derivative · entry 6 Jung Cassie · CIK 0001960154 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2032-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F4 · derivative.exercise_date: This option was granted on August 5, 2022 and is fully vested. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 23:06 UTC |
Jung CassieChief Operating Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001214659-25-013493 · marketforms-70687.xml · derivative · entry 5 Jung Cassie · CIK 0001960154 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2029-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. F3 · derivative.exercise_date: This option was granted on August 9, 2019 and is fully vested. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 23:06 UTC |
Jung CassieChief Operating Officer
|
SaleCommon Stock | 62,180 | $5.00 | $310,900.00 |
DisclosureSEC source: 0001214659-25-013493 · marketforms-70687.xml · nonDerivative · entry 4 Jung Cassie · CIK 0001960154 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,346 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 23:06 UTC |
Jung CassieChief Operating Officer
|
Exercise / conversionCommon Stock | 25,000 | $0.71 | $17,657.50 |
DisclosureSEC source: 0001214659-25-013493 · marketforms-70687.xml · nonDerivative · entry 3 Jung Cassie · CIK 0001960154 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 345,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 23:06 UTC |
Jung CassieChief Operating Officer
|
Exercise / conversionCommon Stock | 25,000 | $3.15 | $78,750.00 |
DisclosureSEC source: 0001214659-25-013493 · marketforms-70687.xml · nonDerivative · entry 2 Jung Cassie · CIK 0001960154 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 320,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 12:41 UTC |
Korczynski SherryChief Commercial Officer
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-012304 · marketforms-70071.xml · nonDerivative · entry 1 Korczynski Sherry · CIK 0002026090 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,858 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| August 09, 2025 Filed Aug 12, 2025 14:11 UTC |
Kraus Carl NChief Medical Officer
|
Tax withholdingCommon Stock | 10,819 | $3.90 | $42,194.10 |
DisclosureSEC source: 0001214659-25-011823 · marketforms-70221.xml · nonDerivative · entry 1 Kraus Carl N · CIK 0001946475 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302,747 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 17:59 UTC |
Krop JulieDirector
|
GrantStock Option (Right to Purchase) · Derivative | 42,000 | $3.41 Strike: $3.41 | $143,220.00 |
DisclosureSEC source: 0001214659-25-009123 · marketforms-69482.xml · derivative · entry 1 Krop Julie · CIK 0001643127 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 13:57 UTC |
Taglietti MarcoDirector
|
GrantStock Option (Right to Purchase) · Derivative | 42,000 | $3.41 Strike: $3.41 | $143,220.00 |
DisclosureSEC source: 0001214659-25-009118 · marketforms-69475.xml · derivative · entry 1 Taglietti Marco · CIK 0001408870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 17:58 UTC |
Cochran JohnDirector
|
GrantStock Option (Right to Purchase) · Derivative | 42,000 | $3.41 Strike: $3.41 | $143,220.00 |
DisclosureSEC source: 0001214659-25-009120 · marketforms-69480.xml · derivative · entry 2 Cochran John · CIK 0001406773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 13:59 UTC |
MORRIS TIMOTHY EDirector
|
GrantStock Option (right to purchase) · Derivative | 42,000 | $3.41 Strike: $3.41 | $143,220.00 |
DisclosureSEC source: 0001214659-25-009122 · marketforms-69483.xml · derivative · entry 1 MORRIS TIMOTHY E · CIK 0001191286 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Mr. Morris' continuous service with the Issuer from the grant date through the applicable vesting date. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 14:13 UTC |
BROWN GREGORY BDirector
|
GrantStock Option (Right to Purchase) · Derivative | 42,000 | $3.41 Strike: $3.41 | $143,220.00 |
DisclosureSEC source: 0001214659-25-009128 · marketforms-69477.xml · derivative · entry 2 BROWN GREGORY B · CIK 0001373585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 17:59 UTC |
Jenkins Abigail L.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 42,000 | $3.41 Strike: $3.41 | $143,220.00 |
DisclosureSEC source: 0001214659-25-009121 · marketforms-69481.xml · derivative · entry 1 Jenkins Abigail L. · CIK 0001947032 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Ms. Jenkins' continuous service with the Issuer from the grant date through the applicable vesting date. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 18:12 UTC |
Korczynski SherrySVP Sales and Marketing
|
Tax withholdingCommon Stock | 2,714 | $3.54 | $9,607.56 |
DisclosureSEC source: 0001214659-25-009047 · marketforms-69905.xml · nonDerivative · entry 1 Korczynski Sherry · CIK 0002026090 · SVP Sales and Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,858 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| May 15, 2025 Filed May 15, 2025 16:59 UTC |
Cioffi MelinaSVP, Regulatory Affairs
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-007749 · marketforms-69454.xml · nonDerivative · entry 1 Cioffi Melina · CIK 0002066841 · SVP, Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,261 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 21:49 UTC |
Wargacki StephenChief Science Officer
|
Tax withholdingCommon Stock | 4,572 | $2.54 | $11,612.88 |
DisclosureSEC source: 0001214659-25-004228 · marketforms-68577.xml · nonDerivative · entry 4 Wargacki Stephen · CIK 0001960165 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,552 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 21:48 UTC |
Jung CassieChief Operating Officer
|
Tax withholdingCommon Stock | 2,182 | $2.54 | $5,542.28 |
DisclosureSEC source: 0001214659-25-004227 · marketforms-68571.xml · nonDerivative · entry 5 Jung Cassie · CIK 0001960154 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,526 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 21:48 UTC |
TOTH A ERNEST JRChief Financial Officer
|
Tax withholdingCommon Stock | 8,736 | $2.65 | $23,150.40 |
DisclosureSEC source: 0001214659-25-004226 · marketforms-68575.xml · nonDerivative · entry 3 TOTH A ERNEST JR · CIK 0001280273 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,366 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 21:49 UTC |
Wargacki StephenChief Science Officer
|
Tax withholdingCommon Stock | 15,431 | $2.65 | $40,892.15 |
DisclosureSEC source: 0001214659-25-004228 · marketforms-68577.xml · nonDerivative · entry 3 Wargacki Stephen · CIK 0001960165 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 348,124 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 21:48 UTC |
Jung CassieChief Operating Officer
|
Tax withholdingCommon Stock | 7,997 | $2.65 | $21,192.05 |
DisclosureSEC source: 0001214659-25-004227 · marketforms-68571.xml · nonDerivative · entry 4 Jung Cassie · CIK 0001960154 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 297,708 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 21:47 UTC |
BRAENDER LORI JChief Legal Officer
|
Tax withholdingCommon Stock | 10,658 | $2.65 | $28,243.70 |
DisclosureSEC source: 0001214659-25-004223 · marketforms-68569.xml · nonDerivative · entry 3 BRAENDER LORI J · CIK 0001752955 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,981 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 21:47 UTC |
Boyd Peter E.See Remark
|
Tax withholdingCommon Stock | 7,681 | $2.65 | $20,354.65 |
DisclosureSEC source: 0001214659-25-004222 · marketforms-68504.xml · nonDerivative · entry 3 Boyd Peter E. · CIK 0001739816 · See Remark 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,323 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 21:47 UTC |
Barber DanielPresident and CEO
|
Tax withholdingCommon Stock | 53,998 | $2.65 | $143,094.70 |
DisclosureSEC source: 0001214659-25-004221 · marketforms-68502.xml · nonDerivative · entry 3 Barber Daniel · CIK 0001742266 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,015,173 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 21:48 UTC |
Korczynski SherrySVP Sales and Marketing
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001214659-25-004224 · marketforms-68572.xml · derivative · entry 3 Korczynski Sherry · CIK 0002026090 · SVP Sales and Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2035-03-07 F3 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 21:48 UTC |
Korczynski SherrySVP Sales and Marketing
|
Tax withholdingCommon Stock | 5,428 | $2.65 | $14,384.20 |
DisclosureSEC source: 0001214659-25-004224 · marketforms-68572.xml · nonDerivative · entry 2 Korczynski Sherry · CIK 0002026090 · SVP Sales and Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,572 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 21:48 UTC |
Korczynski SherrySVP Sales and Marketing
|
GrantCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-004224 · marketforms-68572.xml · nonDerivative · entry 1 Korczynski Sherry · CIK 0002026090 · SVP Sales and Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,000 F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 21:48 UTC |
TOTH A ERNEST JRChief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001214659-25-004226 · marketforms-68575.xml · derivative · entry 4 TOTH A ERNEST JR · CIK 0001280273 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2035-03-07 F3 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.